New FDA Policies Aim To Ease Midstream Reviewer Changes (But Will They Really Help?)
This article was originally published in The Gray Sheet
Executive Summary
The jury is still out on whether CDRH’s new standard operating procedures will improve continuity when a review team changes midstream.